Hemostasis Revenue and Competitors
Estimated Revenue & Valuation
- Hemostasis's estimated annual revenue is currently $11.5M per year.
- Hemostasis's estimated revenue per employee is $251,000
Employee Data
- Hemostasis has 46 Employees.
- Hemostasis grew their employee count by 21% last year.
Hemostasis's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Research, Development, and Engineering | Reveal Email/Phone |
2 | Director Engineering | Reveal Email/Phone |
3 | Quality Manager | Reveal Email/Phone |
4 | Product Manager | Reveal Email/Phone |
5 | Black Ops Specialist | Reveal Email/Phone |
6 | Human Resources | Reveal Email/Phone |
7 | US Sales Director | Reveal Email/Phone |
8 | Production Specialist | Reveal Email/Phone |
9 | Regional Sales Manager | Reveal Email/Phone |
10 | Regional Sales Manager-East | Reveal Email/Phone |
Hemostasis Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $30.6M | 122 | 4% | N/A | N/A |
#2 | $18.6M | 74 | 35% | N/A | N/A |
#3 | $75.6M | 301 | 20% | N/A | N/A |
#4 | $12M | 48 | 4% | N/A | N/A |
#5 | $2.8M | 11 | 10% | N/A | N/A |
#6 | $3M | 12 | 0% | N/A | N/A |
#7 | $24.6M | 98 | 5% | N/A | N/A |
#8 | $11.5M | 46 | 21% | N/A | N/A |
#9 | $7.3M | 29 | 4% | N/A | N/A |
#10 | $13.8M | 55 | -10% | N/A | N/A |
What Is Hemostasis?
Designs and manufactures advanced technology for hemostasis, specifically advanced blood clotting technology. NexStat Topical Hemostat Powder is intended for use under the care of a health care professional as a topical dressing for the temporary treatment of moderate to severely bleeding wounds such as surgical wounds (post-operative, donor sites, dermatological), cuts and lacerations and for the treatment of mild bleeding from topical ENT surgical wounds and nosebleeds. It is also indicated for control of bleeding from the skin at percutaneous needle access, vascular and percutaneous catheter access sites. NexFoam is a versatile sponge that can be used as a spacer, stent and hemostat. It dissolves naturally over 7-14 days or can be easily removed with gentle irrigation. Both NexStat and NexFoam are biocompatible and require no special storage conditions.
keywords:N/AN/A
Total Funding
46
Number of Employees
$11.5M
Revenue (est)
21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.2M | 46 | 39% | N/A |
#2 | $9M | 46 | 15% | N/A |
#3 | $9.9M | 46 | 24% | N/A |
#4 | $9.2M | 46 | 10% | N/A |
#5 | $3.5M | 47 | 42% | N/A |